Page 2 - Bioasis Technologies News Today

Dr. Orfali brings over 25 years of experience across biopharma clinical development and medical practiceAppointment comes at period of rapid growt...

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a large decline in short interest during the month of April. As of April 30th, there was short interest totalling 17,200 shares, a decline of 13.1% from the April 15th total of 19,800 shares. Based on an average daily volume of 8,500 shares, the […]

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 19,800 shares, an increase of 18.6% from the March 31st total of 16,700 shares. Based on an average daily trading volume, of 3,000 shares, the days-to-cover ratio […]

28 April 2023 Biodexa Pharmaceuticals PLC Preliminary Results for the Year Ended 31 December 2022 Biodexa Pharmaceuticals PLC ,... | April 28, 2023

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 16,700 shares, a decline of 42.0% from the March 15th total of 28,800 shares. Based on an average daily volume of 9,400 shares, the […]

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a large decline in short interest in March. As of March 31st, there was short interest totalling 16,700 shares, a decline of 42.0% from the March 15th total of 28,800 shares. Based on an average daily trading volume, of 9,400 shares, the days-to-cover ratio is currently 1.8 […]

Bioasis Technologies Inc. (OTCMKTS:BIOAF – Get Rating) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 28,800 shares, a drop of 40.9% from the February 28th total of 48,700 shares. Based on an average daily volume of 44,000 shares, the days-to-cover ratio is […]

NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage progr...

Investegate announcements from Midatech Pharma PLC, Result of General Meeting

NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare...